Showing results (61-70 of 343) with videos related to
Sort By:
Pageof 35
Molecular Genetics & Genomic Medicine|November 14, 2022
Using reported pathogenic variants to identify therapeutic opportunities for genetic diseasesAndrew K Ressler, David B GoldsteinDialogues in Clinical Neuroscience|April 9, 2010
Whole genome association studies in complex diseases: where do we stand?Anna C Need, David B GoldsteinCurrent Neurology and Neuroscience Reports|August 31, 2015
Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the EpilepsiesRyan S Dhindsa, David B GoldsteinCurrent Biology : CB|January 16, 2003
Demography, recombination hotspot intensity, and the block structure of linkage disequilibriumMichael P H Stumpf, David B GoldsteinTrends in Biotechnology|May 20, 2015
Academic-industrial partnerships in drug discovery in the age of genomicsTim Harris, Stelios Papadopoulos, David B GoldsteinNature Reviews. Drug Discovery|December 9, 2017
Drug development in the era of precision medicineSarah A Dugger, Adam Platt, David B GoldsteinExpert Opinion on Pharmacotherapy|July 15, 2005
The role of common variation in drug transporter genes in refractory epilepsyNicole Soranzo, David B Goldstein, Sanjay M SisodiyaNature Reviews. Genetics|November 25, 2003
Pharmacogenetics goes genomicDavid B Goldstein, Sarah K Tate, Sanjay M SisodiyaGenome Biology|March 31, 2012
Modifier genetics in neuropsychiatric disease: challenges and opportunitiesElizabeth K Ruzzo, Andrea L Pappas, David B GoldsteinNature Genetics|July 2, 2005
Priorities and standards in pharmacogenetic researchAnna C Need, Arno G Motulsky, David B GoldsteinPageof 35